Temperature and pH sensitive hydrogels: An approach towards smart semen-triggered vaginal microbicidal vehicles

被引:61
作者
Gupta, Kavita M.
Barnes, Scott R.
Tangaro, Rachel A.
Roberts, Meredith C.
Owen, Derek H.
Katz, David F.
Kiser, Patrick F.
机构
[1] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA
[2] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA
关键词
HIV/AIDS; microbicide; formulation vehicle; viscosity; thermal gels; responsive delivery system; semen-triggered drug release; controlled release/delivery; vaginal coating; retention;
D O I
10.1002/jps.20752
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Microbicides are drug delivery systems (DDSs) for the prevention of sexual transmission of HIV and other STDs. A topically applied vaginal microbicidal gel should provide uniform coating of vaginal tissue, retention of this gel layer prior to intercourse, and controlled release kinetics of antivirals to inactivate the viral load potentially introduced during sexual activity. Here, we describe the microbicide-oriented characterization of a DDS made with a dual pH sensitive and thermosensitive smart polymer gel composed of a random terpolymer of N-isopropyl acrylamide, butyl methacrylate, and acrylic acid. The system was engineered to coat vaginal tissue with a stable gel layer and to release entrapped model agents in a burst release profile in response to the presence of the infecting agent: semen. The gel rheology, layer erosion properties, model drug release kinetics, and cytocompatibility of the terpolymer system were studied. Negligible erosion of the gel in the presence of vaginal fluid simulant suggests prolonged retention. Burst release of molecular and macromolecular model compounds was observed when the system's pH changed from the vaginal pH to the pH of semen, and cytotoxicity studies showed that the terpolymer is equally cytocompatible as a commonly used polymeric vaginal carrier. (c) 2006 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:670 / 681
页数:12
相关论文
共 40 条
[1]   Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis [J].
Achilles, SL ;
Shete, PB ;
Whaley, KJ ;
Moench, TR ;
Cone, RA .
SEXUALLY TRANSMITTED DISEASES, 2002, 29 (11) :655-664
[2]  
BERGERON MG, 1997, POLYM MAT SCI ENG, V76, P278
[3]   Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model [J].
Chakraborty, H ;
Sen, PK ;
Helms, RW ;
Vernazza, PL ;
Fiscus, SA ;
Eron, JJ ;
Patterson, BK ;
Coombs, RW ;
Krieger, JN ;
Cohen, MS .
AIDS, 2001, 15 (05) :621-627
[4]   Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions [J].
Chang, JY ;
Oh, YK ;
Choi, HG ;
Kim, YB ;
Kim, CK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 241 (01) :155-163
[5]   Gels as vaginal drug delivery systems [J].
das Neves, J. ;
Bahia, M. F. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 318 (1-2) :1-14
[6]  
Doncel GF, 2004, JAIDS-J ACQ IMM DEF, V37, pS174, DOI 10.1097/00126334-200410013-00008
[7]   High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa [J].
Dyer, JR ;
Kazembe, P ;
Vernazza, PL ;
Gilliam, BL ;
Maida, M ;
Zimba, D ;
Hoffman, IF ;
Royce, RA ;
Schock, JL ;
Fiscus, SA ;
Cohen, MS ;
Eron, JJ .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (06) :1742-1746
[8]   Development and characterization of bioadhesive vaginal films of sodium polystyrene sulfonate (PSS), a novel contraceptive antimicrobial agent [J].
Garg, S ;
Vermani, K ;
Garg, A ;
Anderson, RA ;
Rencher, WB ;
Zaneveld, LJD .
PHARMACEUTICAL RESEARCH, 2005, 22 (04) :584-595
[9]   Development pharmaceutics of microbicide formulations. Part II: Formulation, evaluation, and challenges [J].
Garg, S ;
Tambwekar, KR ;
Vermani, K ;
Kandarapu, R ;
Garg, A ;
Waller, DP ;
Zaneveld, LJD .
AIDS PATIENT CARE AND STDS, 2003, 17 (08) :377-399
[10]  
GARG S, 2001, PHARM TECHNOL DRUG D, V11, P14